Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Pruritus in Sezary Syndrome
NCT01625455Phase 4Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant in pruritus, sponsored by Vanderbilt University Medical Center. Started Feb 2012; status: terminated.
02
Drugs
aprepitant
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT01625455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625455.